EUSOMA review of mammography screening.
In 1993 the European Society of Mastology concluded that regular mammography screening reduces the risk of dying from breast cancer. The evidence came from a meta-analysis of six randomised controlled trials that collectively showed a statistically significant 22% reduction in breast cancer mortality. The effect is clear in women aged >/=50 years but there is uncertainty in women aged <50 years. Screening programmes for women aged >/=50 years should be part of organised public health programmes. The adverse effects of screening were addressed and performance indicators of programmes were specified.
Hackshaw
A
A
Cancer Research UK & UCL Cancer Trials Centre, University College London, London, UK. ah@ctc.ucl.ac.uk
D000328:Adult; D017677:Age Distribution; D000368:Aged; D001943:Breast Neoplasms / Q000401:mortality* / Q000517:prevention & control*; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D015994:Incidence; D008327:Mammography / Q000379:methods*; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016019:Survival Analysis